OLFML3 and neoplasm: In CRC patients, OLFML3 mRNA expression positively correlated with shorter RFS, the angiogenic CMS4 subtype, and transcripts encoding proangiogenic and lymphangiogenic factors, and negatively with antiangiogenic molecules, suggesting a role for OLFML3 in tumor angiogenesis and lymphangiogenesis.